230 related articles for article (PubMed ID: 31987863)
1. Adjunctive effect of the serotonin 5-HT
Sierra S; Lippold KM; Stevens DL; Poklis JL; Dewey WL; González-Maeso J
Neuropharmacology; 2020 May; 167():107949. PubMed ID: 31987863
[TBL] [Abstract][Full Text] [Related]
2. Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.
Neelakantan H; Holliday ED; Fox RG; Stutz SJ; Comer SD; Haney M; Anastasio NC; Moeller FG; Cunningham KA
ACS Chem Neurosci; 2017 May; 8(5):1065-1073. PubMed ID: 28107783
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific role for serotonin 5-HT
Sierra S; Muchhala KH; Jessup DK; Contreras KM; Shah UH; Stevens DL; Jimenez J; Cuno Lavilla XK; de la Fuente Revenga M; Lippold KM; Shen S; Poklis JL; Qiao LY; Dewey WL; Akbarali HI; Damaj MI; González-Maeso J
Neuropharmacology; 2022 May; 209():108988. PubMed ID: 35183539
[TBL] [Abstract][Full Text] [Related]
4. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
[TBL] [Abstract][Full Text] [Related]
5. A short history of the 5-HT
Palacios JM; Pazos A; Hoyer D
Psychopharmacology (Berl); 2017 May; 234(9-10):1395-1418. PubMed ID: 28265714
[TBL] [Abstract][Full Text] [Related]
6. The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine.
Zeeb FD; Higgins GA; Fletcher PJ
ACS Chem Neurosci; 2015 Jul; 6(7):1231-40. PubMed ID: 25781911
[TBL] [Abstract][Full Text] [Related]
7. Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration.
Anastasio NC; Sholler DJ; Fox RG; Stutz SJ; Merritt CR; Bjork JM; Moeller FG; Cunningham KA
Neuropharmacology; 2020 May; 168():108009. PubMed ID: 32145488
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles.
Higgins GA; Silenieks LB; Lau W; de Lannoy IA; Lee DK; Izhakova J; Coen K; Le AD; Fletcher PJ
Psychopharmacology (Berl); 2013 Apr; 226(3):475-90. PubMed ID: 23184281
[TBL] [Abstract][Full Text] [Related]
9. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice.
Zhang G; Wu X; Zhang YM; Liu H; Jiang Q; Pang G; Tao X; Dong L; Stackman RW
Neuropharmacology; 2016 Feb; 101():246-54. PubMed ID: 26432939
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-HT
Higgins GA; Brown M; St John J; MacMillan C; Silenieks LB; Thevarkunnel S
Neuropharmacology; 2020 Jun; 170():108064. PubMed ID: 32222404
[TBL] [Abstract][Full Text] [Related]
11. Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice.
Maguire DR
Pharmacol Biochem Behav; 2024 Jan; 234():173673. PubMed ID: 37951365
[TBL] [Abstract][Full Text] [Related]
12. Repeated 7-Day Treatment with the 5-HT
Banks ML; Negus SS
Neuropsychopharmacology; 2017 Apr; 42(5):1082-1092. PubMed ID: 27857126
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats.
Gannon BM; Sulima A; Rice KC; Collins GT
J Pharmacol Exp Ther; 2018 Mar; 364(2):359-366. PubMed ID: 29217539
[TBL] [Abstract][Full Text] [Related]
14. Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord.
Dogrul A; Seyrek M
Br J Pharmacol; 2006 Nov; 149(5):498-505. PubMed ID: 16921395
[TBL] [Abstract][Full Text] [Related]
15. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
16. Directly Observable Behavioral Effects of Lorcaserin in Rats.
Serafine KM; Rice KC; France CP
J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
[TBL] [Abstract][Full Text] [Related]
17. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
18. Interplay between 5-HT
Baptista-de-Souza D; Pelarin V; Canto-de-Souza L; Nunes-de-Souza RL; Canto-de-Souza A
Neuropharmacology; 2018 Sep; 140():100-106. PubMed ID: 30056125
[TBL] [Abstract][Full Text] [Related]
19. Functional Profile of Systemic and Intrathecal Cebranopadol in Nonhuman Primates.
Ding H; Trapella C; Kiguchi N; Hsu FC; Caló G; Ko MC
Anesthesiology; 2021 Sep; 135(3):482-493. PubMed ID: 34237134
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
